Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Montanino · SciRah

Researcher profile · Semantic Scholar

A. Montanino

Share profile

A. Montanino — researcher profile on SciRah

h-index: 21
Works: 60
Citations: 1,653

Most-cited papers

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.
M. de Laurentiis, G. Cancello, D. D'Agostino, M. Giuliano +12 more
2008Journal of Clinical Oncology401 citations Open access
Semantic Scholar
Angiogenesis Inhibitors in NSCLC
A. Manzo, A. Montanino, G. Carillio, R. Costanzo +7 more
2017International Journal of Molecular Sciences95 citations Open access
Semantic Scholar
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma
A. Rachiglio, R. E. Abate, A. Sacco, R. Pasquale +14 more
2016OncoTarget92 citations Open access
Semantic Scholar
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
N. Normanno, A. Rossi, A. Morabito, S. Signoriello +9 more
2014Lung Cancer67 citations
Semantic Scholar
The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
A. Rachiglio, F. Fenizia, M. Piccirillo, D. Galetta +16 more
2019Cancers63 citations Open access
Semantic Scholar
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.
F. Perrone, F. Nuzzo, F. Di Rella, A. Gravina +26 more
2015Annals of Oncology63 citations
Semantic Scholar
Immunotherapy in Small Cell Lung Cancer
G. Esposito, G. Palumbo, G. Carillio, A. Manzo +16 more
2020Cancers61 citations Open access
Semantic Scholar
RET Inhibitors in Non-Small-Cell Lung Cancer
Priscilla Cascetta, V. Sforza, A. Manzo, G. Carillio +14 more
2021Cancers60 citations Open access
Semantic Scholar
Gefitinib in Non Small Cell Lung Cancer
R. Costanzo, M. Piccirillo, C. Sandomenico, G. Carillio +10 more
2011Journal of Biomedicine and Biotechnology60 citations Open access
Semantic Scholar
Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients
V. Granata, R. Fusco, Matilde Costa, C. Picone +12 more
2021Cancers56 citations Open access
Semantic Scholar
Angiogenesis Inhibitors in Small Cell Lung Cancer
A. Montanino, A. Manzo, G. Carillio, G. Palumbo +11 more
2021Frontiers in Oncology55 citations Open access
Semantic Scholar
Quantitative imaging decision support (QIDSTM) tool consistency evaluation and radiomic analysis by means of 594 metrics in lung carcinoma on chest CT scan
R. Fusco, V. Granata, M. Mazzei, N. Di Meglio +11 more
2021Cancer Control: Journal of the Moffitt Cancer Cente54 citations Open access
Semantic Scholar
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
A. Morabito, V. Gebbia, M. di Maio, S. Cinieri +19 more
2013Lung Cancer52 citations
Semantic Scholar
Cetuximab in non-small-cell lung cancer
G. Carillio, A. Montanino, R. Costanzo, C. Sandomenico +9 more
2012Expert Review of Anticancer Therapy46 citations
Semantic Scholar
Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer.
F. Cappuzzo, A. Morabito, N. Normanno, P. Bidoli +15 more
2016Lung Cancer39 citations
Semantic Scholar
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer.
C. Gridelli, A. Rossi, F. Ciardiello, F. de Marinis +9 more
2016Clinical Lung Cancer39 citations
Semantic Scholar
Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors.
P. Giordano, A. Manzo, A. Montanino, R. Costanzo +9 more
2016Critical reviews in oncology/hematology37 citations
Semantic Scholar
Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.
R. Pasquale, F. Fenizia, R. Esposito Abate, A. Sacco +12 more
2015Pharmacogenomics (London)30 citations
Semantic Scholar
BRAF Inhibitors in Non-Small Cell Lung Cancer
V. Sforza, G. Palumbo, Priscilla Cascetta, G. Carillio +14 more
2022Cancers29 citations Open access
Semantic Scholar
Lurbinectedin in small cell lung cancer
A. Manzo, V. Sforza, G. Carillio, G. Palumbo +15 more
2022Frontiers in Oncology27 citations Open access
Semantic Scholar
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study
R. Berardi, C. Mastroianni, Giuseppe Lo Russo, R. Buosi +34 more
2019Therapeutic Advances in Medical Oncology27 citations Open access
Semantic Scholar
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
A. Camerini, A. Morabito, A. Montanino, R. Bernabé +11 more
2021ESMO Open18 citations Open access
Semantic Scholar
Bevacizumab in non small cell lung cancer: development, current status and issues.
Claudia Sandomenico, R. Costanzo, Guido Carillio, M. Piccirillo +6 more
2012Current Medicinal Chemistry18 citations
Semantic Scholar
Treatment of small cell lung cancer.
A. Morabito, G. Carillio, G. Daniele, M. Piccirillo +8 more
2014Critical reviews in oncology/hematology17 citations
Semantic Scholar
Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations.
A. Morabito, R. Costanzo, A. Rachiglio, R. Pasquale +6 more
2013Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives
R. Costanzo, A. Montanino, M. di Maio, M. Piccirillo +8 more
2013Expert Review of Anticancer Therapy14 citations
Semantic Scholar
Focus on Nintedanib in NSCLC and Other Tumors
A. Manzo, G. Carillio, A. Montanino, R. Costanzo +3 more
2016Frontiers in Medicine13 citations Open access
Semantic Scholar
Non small-cell lung cancer with metastasis to thigh muscle and mandible: two case reports
F. Giugliano, Domingo Alberti, Giovanna Guida, G. de Palma +7 more
2013Journal of Medical Case Reports12 citations Open access
Semantic Scholar
Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working
A. Morabito, E. Mercadante, Paolo Muto, A. Manzo +16 more
2024Exploration of Targeted Anti-tumor Therapy11 citations Open access
Semantic Scholar
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
Giacomo Pascarella, Arturo Capasso, A. Nardone, M. Triassi +16 more
2019PLoS ONE10 citations Open access
Semantic Scholar
EGFR Mutations
A. Manzo, A. Montanino, R. Costanzo, C. Sandomenico +6 more
2019Oncogenomics9 citations
Semantic Scholar
Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib.
A. Morabito, C. Sandomenico, R. Costanzo, A. Montanino +8 more
2012Journal of Thoracic Oncology9 citations Open access
Semantic Scholar
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.
A. Morabito, M. Piccirillo, P. Maione, A. Luciani +26 more
2019Lung Cancer7 citations
Semantic Scholar
Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies.
C. Gridelli, A. Morabito, L. Cavanna, A. Luciani +16 more
20177 citations
Semantic Scholar
Immunotherapy Assessment: A New Paradigm for Radiologists
V. Granata, R. Fusco, S. Setola, I. Simonetti +10 more
2023Diagnostics6 citations Open access
Semantic Scholar
Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….
M. di Maio, A. Morabito, M. Piccirillo, G. Daniele +6 more
2014Current pharmaceutical design6 citations
Semantic Scholar
Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer.
M. di Maio, R. Costanzo, P. Giordano, M. Piccirillo +9 more
2013Anti-Cancer Agents in Medicinal Chemistry6 citations
Semantic Scholar
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
G. Palumbo, G. Esposito, G. Carillio, A. Manzo +16 more
2020Exploration of Targeted Anti-tumor Therapy5 citations Open access
Semantic Scholar
Pembrolizumab in lung cancer: current evidence and future perspectives.
G. Palumbo, G. Carillio, A. Manzo, A. Montanino +15 more
2019Future Oncology5 citations
Semantic Scholar
Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis
A. Morabito, E. Mercadante, P. Muto, G. Palumbo +20 more
2022JCO Oncology Practice4 citations
Semantic Scholar
Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?
C. Picone, Annamaria Porto, R. Fusco, V. Granata +15 more
2025Cancer Control: Journal of the Moffitt Cancer Cente3 citations Open access
Semantic Scholar
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion
A. Morabito, A. Manzo, A. Montanino, A. Rachiglio +14 more
2022The Oncologist2 citations Open access
Semantic Scholar
The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer
A. Manzo, G. Carillio, A. Montanino, V. Sforza +16 more
2020Expert Opinion on Drug Safety2 citations
Semantic Scholar
Final results of randomized phase II trial of metronomic vs weekly oral vinorelbine (OV) as first-line chemotherapy (CT) in advanced NSCLC patients unfit to platinum-based CT (P-CT): Tempo-Lung
D. Kowalski, A. Morabito, A. Montanino, R. Bernabé +11 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
1365PEffect on quality of life (QOL) of adding cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicentre, randomized, phase 3 MILES-3 and MILES-4 studies
M. Piccirillo, A. Morabito, P. Maione, A. Luciani +16 more
20171 citations Open access
Semantic Scholar
Prognostic evaluation and choice of second-line treatment for patients with advanced non-small-cell lung cancer
M. di Maio, A. Morabito, G. Daniele, P. Giordano +7 more
20121 citations
Semantic Scholar
HER2status and efficay of taxane-based adjuvant therapy of early breast cancer (EBC): a metanalysis of randomized trials involving 7,831 patients.
M. de Laurentiis, C. Criscitiello, A. Giordano, M. Giuliano +4 more
20091 citations
Semantic Scholar
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.
M. Iacovino, L. Arenare, A. Morabito, M. Tiseo +25 more
2026Lung Cancer0 citations Open access
Semantic Scholar
An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital Setting
A. Morabito, P. Maiolino, S. D'Auria, R. D'Aniello +21 more
2026Risk Management and Healthcare Policy0 citations Open access
Semantic Scholar
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL.
P. Medusa, N. Carro, F. Morgillo, G. Di Guida +32 more
2025Lung Cancer0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Morabito×38
Invite
A. Morabito — researcher profile on SciRah
R. Costanzo×28
Invite
R. Costanzo — researcher profile on SciRah
C. Sandomenico×28
Invite
C. Sandomenico — researcher profile on SciRah
M. Piccirillo×26
Invite
M. Piccirillo — researcher profile on SciRah

×25

Invite

N. Normanno — researcher profile on SciRah

Invite

A. Manzo — researcher profile on SciRah

Invite

F. Perrone — researcher profile on SciRah

Invite

G. Rocco — researcher profile on SciRah

Invite

G. Daniele — researcher profile on SciRah

G. Carillio×15

Invite

G. Carillio — researcher profile on SciRah

Invite

G. Palumbo — researcher profile on SciRah

Invite

C. Picone — researcher profile on SciRah